Federal University of Goiás, UFG, Av. Das nações, nº 105, ap 503, Jardim Bandeirante, Anápolis, Goiás, 75083-050, Brazil.
Eur Arch Otorhinolaryngol. 2020 Jun;277(6):1815-1822. doi: 10.1007/s00405-020-05878-z. Epub 2020 Mar 10.
Post-tonsillectomy pain is mediated by nociceptive C-fibers located at peritonsillar space. Peritonsillar infiltration of medication could relieve post-operative pain blocking the afferent via.
To evaluate the effect of peritonsillar infiltration of tramadol, ketamine, and placebo on post-operative pain in cases of adenotonsillectomy.
This is a double-blind randomized placebo-controlled study. Children ASA I-II aged 3-13 years scheduled for adenotonsillectomy were included in the study. Patients were randomized to receive either 2 mg/kg of peritonsillar tramadol (Group T), 0.5 mg/kg of peritonsillar ketamine hydrochloride (Group K), and 3 mL of peritonsillar saline (Group P). Post-operative pain was recorded using the modified visual analogue scale at 2 h, 6 h, 12 h, and 24 h. Side effects, analgesia requirement, and first oral intake were also recorded.
There were included 112 patients and five were excluded until final evaluation. We evaluated 36 children of Group T, 36 of Group K, and 35 of Group P. Groups were similar regarding to age, weight, height, gender, tonsil and adenoid size, hemodynamic parameters during the surgery, surgery, and anesthesia time. There were no differences between the groups in relation to pain scores, analgesia requirement, or first time of oral intake (p > 0.05). Group T presented a higher incidence of vomit between 2 and 6 h after surgery (p > 0.05).
This study showed that peritonsillar infiltration of tramadol or ketamine were not superior to placebo in reducing post-operative pain in children undergone adenotonsillectomy. The use of tramadol increased the risk of nausea and vomit between 2 and 6 h after surgery.
扁桃体切除术后疼痛是由位于扁桃体周围间隙的伤害性 C 纤维介导的。扁桃体周围药物浸润可以通过阻断传入神经来缓解术后疼痛。
评估在扁桃体腺样体切除术患者中,扁桃体周围注射曲马多、氯胺酮和安慰剂对术后疼痛的影响。
这是一项双盲随机安慰剂对照研究。纳入年龄 3-13 岁、ASA 分级 I-II 级、拟行扁桃体腺样体切除术的儿童患者。患者被随机分为三组,分别接受 2mg/kg 扁桃体周围注射曲马多(T 组)、0.5mg/kg 扁桃体周围注射盐酸氯胺酮(K 组)和 3ml 扁桃体周围生理盐水(P 组)。术后 2h、6h、12h 和 24h 使用改良视觉模拟评分法记录术后疼痛。记录不良反应、镇痛需求和首次口服摄入情况。
共纳入 112 例患者,其中 5 例在最终评估前退出。我们评估了 T 组 36 例、K 组 36 例和 P 组 35 例。三组在年龄、体重、身高、性别、扁桃体和腺样体大小、手术期间血流动力学参数、手术和麻醉时间方面无差异。三组间疼痛评分、镇痛需求或首次口服摄入时间无差异(p>0.05)。T 组术后 2-6h 呕吐发生率较高(p>0.05)。
本研究表明,扁桃体周围注射曲马多或氯胺酮并不能降低扁桃体腺样体切除术后儿童的术后疼痛。曲马多的使用增加了术后 2-6h 恶心和呕吐的风险。